Eclipse
Eclipse operates in the medical aesthetics industry, marketing FDA-cleared microneedling devices (SkinPen, MicroPen Evo), PRP preparation systems (ProGen), and topical skincare (BIOJUVE) to dermatologists, plastic surgeons, and aesthetic practices globally as part of the Revance portfolio.
- Company typePrivate
- Founded1993
- HeadquartersSanger, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eclipse does
Eclipse operates in the medical aesthetics industry and aligns with the Crown Aesthetics business unit of Revance (the entity formed by the merger of Crown Laboratories and Revance Therapeutics in 2025). The company sells an integrated portfolio of FDA-cleared aesthetic devices and skincare products to dermatologists, plastic surgeons, and medical aesthetic practices. Core devices include the SkinPen Precision Elite and MicroPen Evo microneedling systems, the latter indicated specifically for improvement of neck wrinkles (Fitzpatrick II-IV) and facial acne scars in adults aged 22 and older (Rx only), and the ProGen PRP system for point-of-care autologous platelet-rich plasma preparation. Skincare and ancillary aesthetic products include BIOJUVE, a topical line marketed as breakthrough skin science, plus Votesse. The portfolio is supported by FDA 510(k)-equivalent clearance (DEN160029) for SkinPen, CE Mark for European distribution, and ISO certification via the affiliated Bellus Medical entity.
Eclipse firmographics
Firmographics- Name
- Eclipse
- Legal name
- Crown Aesthetics
- Website
- https://eclipsemed.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eclipse operates in the medical aesthetics industry, marketing FDA-cleared microneedling devices (SkinPen, MicroPen Evo), PRP preparation systems (ProGen), and topical skincare (BIOJUVE) to dermatologists, plastic surgeons, and aesthetic practices globally as part of the Revance portfolio.
- Ownership category
- akta.pro rank
Eclipse industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Professional Skincare & Facial Treatments (CRABALAF)
- akta.pro secondary industries
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)
Keywords
Where Eclipse is headquartered
LocationHeadquarters
- HQ city
- Sanger
- HQ country
- United States
- HQ region
- North America
Markets served
Eclipse business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Sale of aesthetic medical devices including SkinPen Precision Elite microneedling systems and MicroPen Evo to aesthetic practices and medical professionals. These are capital equipment purchases for provider offices.
- Consumables and Supplies: Ongoing sales of consumable products including PRP kits (ProGen), treatment serums, and skincare products (BIOJUVE) that providers purchase for use with their patients during procedures.
- Provider Training and Education: Education and training programs for aesthetic providers on proper use of products, with events and certification programs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Eclipse product offering
Product offeringCore offering
Eclipse operates in the aesthetics industry, providing FDA-cleared medical aesthetic devices and skincare products to aesthetic medical practices. The portfolio includes microneedling systems (SkinPen Precision Elite, MicroPen Evo), platelet-rich plasma preparation systems (ProGen PRP), and topical skincare lines (BIOJUVE, Votesse). Products are sold exclusively through a network of certified aesthetic providers, dermatologists, and plastic surgeons for use in clinical patient treatments.
Product overview
Crown Aesthetics, a Revance Company, offers a comprehensive portfolio of aesthetic and skincare products. The product lineup includes SkinPen Precision Elite (microneedling device for wrinkle improvement and acne scar treatment), BIOJUVE (skincare product optimizing skin health), PROGEN PRP (platelet-rich plasma system), MicroPen Evo (microneedling device), and Votesse (aesthetic treatment). These products serve aesthetic practices and healthcare providers with rejuvenation and restoration solutions.
Differentiator
Problem solved
Functional benefit
Brands
- BIOJUVE: Breakthrough skin science that optimizes skin health on and below the surface.
- SkinPen Precision Elite
- ProGen PRP
- MicroPen Evo
- Votesse
Products and services
- SkinPen Precision Elite FDA-cleared microneedling device intended to improve the appearance of wrinkles of the neck for Fitzpatrick skin types II-IV and to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types aged 22 years and older. Rx only. Internationally used for collagen induction therapy to treat melasma, acne, and surgical scars. Sold to aesthetic medical practices and providers.
- BIOJUVE Topical skincare product line based on breakthrough skin science that optimizes skin health on and below the surface. Sold through aesthetic medical practices for daily skincare maintenance offerings.
- ProGen PRP System Flexible Platelet-Rich Plasma system for rapid preparation of autologous PRP from a small sample of blood at the patient's point of care. Indicated for mixing with autograft/allograft bone prior to application to bony defects. Sold to medical practices for regenerative aesthetic procedures.
- MicroPen Evo Microneedling device for aesthetic treatments, designed for ease of use and implementation in clinical practice. Sold to aesthetic medical providers.
- Votesse Aesthetic treatment product in the Eclipse portfolio addressing domain-specific skin and aesthetic needs. Sold through certified aesthetic providers.
Quantifiable outcome
- SkinPen is indicated for improvement of facial acne scars in adults aged 22+ with all Fitzpatrick skin types and for wrinkles of the neck for Fitzpatrick types II-IV.
Companies that use Eclipse
Customer profileSegments2 records
Ideal customer profiles1 record
Eclipse technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Eclipse partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Eclipse competitors and assessment
Company assessmentBroad incumbents
- InMode: InMode is a publicly traded medical aesthetics company with a portfolio that includes Morpheus8 (RF microneedling), directly competing with SkinPen in the fractional/collagen-induction category and increasingly capturing share.
- BTL Aesthetics: BTL Aesthetics manufactures non-invasive body contouring, skin tightening, and feminine wellness devices sold to aesthetic practices; competes for the same capital equipment wallet of dermatologists and med-spas.
- Cutera: Cutera is an established medical aesthetics device company offering energy-based platforms (lasers, RF, microneedling with RF) sold to dermatologists and plastic surgeons; broader portfolio but overlaps with Crown Aesthetics at the aesthetic practice call point.
- Cynosure (Hologic): Cynosure is a global aesthetics device manufacturer offering laser, RF, and body-contouring platforms to medical spas and dermatology practices; competes broadly for the same capital equipment budget allocated by aesthetic providers.
- Galderma: Galderma is a global dermatology-focused company offering prescription aesthetics (Dysport, Restylane, Sculptra) and a therapeutic skincare line (Cetaphil, Alastin); overlaps with Crown Aesthetics on the dermatology call point and on medical-grade skincare adjacencies.
- Merz Aesthetics: Merz Aesthetics offers injectables (Xeomin, Radiesse, Belotero), devices (Ultherapy), and skincare (Neocutis); shares the same dermatologist and plastic surgeon customers and competes for the broader aesthetic treatment menu.
Direct peers
- Eclipse MedCorp: Eclipse MedCorp manufactures microneedling devices (Eclipse MicroPen) and PRP systems sold to medical aesthetics practices; directly competes with SkinPen Precision Elite, MicroPen Evo, and ProGen PRP on the same provider call points and the same clinical indications.
- Bellus Medical: Bellus Medical (acquired by Crown Laboratories) is a medical aesthetics company offering skin resurfacing devices and skincare products; directly overlaps with Crown Aesthetics' microneedling and skincare portfolio and shares the same provider network.
Emerging players
- EndyMed Medical: EndyMed Medical manufactures RF microneedling and skin rejuvenation devices for medical aesthetic practices; directly competes with SkinPen in the collagen induction therapy category with an energy-based modality.
Others
- Crown Laboratories: Crown Laboratories is the former parent of Crown Aesthetics and sister entity within Revance; operates in adjacent skincare and consumer health categories that overlap on distribution and brand assets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Eclipse social profiles
Digital presenceEclipse compliance and trust
Trust signalCompliance3 records
Eclipse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eclipse leadership team
Management profileNumber of profiles
Profiles1 record
Eclipse funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eclipse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eclipse
What does Eclipse do?
Eclipse operates in the aesthetics industry, providing FDA-cleared medical aesthetic devices and skincare products to aesthetic medical practices. The portfolio includes microneedling systems (SkinPen Precision Elite, MicroPen Evo), platelet-rich plasma preparation systems (ProGen PRP), and topical skincare lines (BIOJUVE, Votesse). Products are sold exclusively through a network of certified aesthetic providers, dermatologists, and plastic surgeons for use in clinical patient treatments.
Is Eclipse a public or private company?
Eclipse is a private company. It is classified as unknown and is currently operating.
When was Eclipse founded?
Eclipse was founded in 1993. It employs 11 to 50 people.
Where is Eclipse based?
Eclipse is headquartered in Sanger, United States, in the North America region.
How does Eclipse make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are consumables and Supplies and provider Training and Education.
Who are Eclipse's main competitors?
Broad incumbents on record are InMode, BTL Aesthetics, Cutera, Cynosure (Hologic), Galderma and Merz Aesthetics. Direct peers are Eclipse MedCorp and Bellus Medical. EndyMed Medical is listed as an emerging player. Crown Laboratories is listed as an others.
Does Eclipse have an API?
No public API is recorded for Eclipse.
What industry is Eclipse in?
Eclipse's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is CRABALAF, Professional Skincare & Facial Treatments, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3391 and its SIC code is 2844.